Figure 4From: Blockade of phospholipid scramblase 1 with its N-terminal domain antibody reduces tumorigenesis of colorectal carcinomas in vitro and in vivoAnti-PLSCR1 inhibits growth of xenogenic transplanted HT29 tumors. (A) Representative photographs of a mouse from each group at day 7 and day 30 are shown. Arrows indicate tumor nodules. (B) Tumors dissected from groups treated with isotype-control IgG or NP1 are shown below. (C) Tumor growth curve were evaluated until day 30 and (D) final average tumor weight from mice treated with isotype-control IgG or NP1. Data are mean ± SD of 12 samples from twice experiments. * p < 0.05.Back to article page